Home
CTLT
CTLT News

Latest Catalent Inc. (CTLT) News on December 18, 2024

Novo Completes $16.5 Billion Acquisition of Catalent

GuruFocus.com

4 hours ago

Novo Completes $16.5 Billion Acquisition of Catalent

MT Newswires

9 hours ago

Correction: Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout

MT Newswires

9 hours ago

Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout

Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent

Reuters

9 hours ago

Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent

Business Wire

9 hours ago

Novo Holdings Completes Acquisition of Catalent

Argus Research

a day ago

CTLT: Raising target price to $67.00

NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark

Zacks

a day ago

NVO to Invest $1.2B in New Rare Disease Drugs Facility in Denmark

Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.

Barrons.com

2 days ago

Novo’s New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way.

MT Newswires

2 days ago

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires

2 days ago

Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

Benzinga

2 days ago

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

MT Newswires

2 days ago

Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared

Novo Holdings’ purchase of Catalent set to close after regulators’ green light

BioPharma Dive

3 days ago

Novo Holdings’ purchase of Catalent set to close after regulators’ green light

Novo Nordisk to Invest $1.2 Billion in New Production Facility in Denmark

The Wall Street Journal

3 days ago

Novo Nordisk to Invest $1.2 Billion in New Production Facility in Denmark

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

Reuters

4 days ago

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say

Business Wire

5 days ago

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction

Argus Research

8 days ago

CTLT: What does Argus have to say about CTLT?

Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue

Barrons.com

9 days ago

Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue

Novo Holdings’ acquisition of Catalent gains EC approval

Pharmaceutical Technology

9 days ago

Novo Holdings’ acquisition of Catalent gains EC approval

MT Newswires

12 days ago

Catalent's Proposed Acquisition by Novo Holdings Wins European Commission Nod

Business Wire

12 days ago

Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction

Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval

Reuters

12 days ago

Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?

Zacks

12 days ago

Why Is Catalyst (CPRX) Down 6.7% Since Last Earnings Report?

Why Is Catalent (CTLT) Up 3.2% Since Last Earnings Report?

Zacks

13 days ago

Why Is Catalent (CTLT) Up 3.2% Since Last Earnings Report?

Argus Research

15 days ago

CTLT: Raising target price to $65.00

Argus Research

22 days ago

CTLT: Raising target price to $64.00

MT Newswires

23 days ago

Update: Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover

MT Newswires

23 days ago

Market Chatter: Novo Holdings to Win EU Approval for $16.5 Billion Catalent Takeover

Melt reports topline outcomes from trial of MELT-300 for cataract surgery

Clinical Trials Arena

a month ago

Melt reports topline outcomes from trial of MELT-300 for cataract surgery

Morningstar Research

a month ago

Analyst Report: Catalent, Inc.

Avid Bioservices, Inc. (CDMO): A Bull Case Theory

Insider Monkey

a month ago

Avid Bioservices, Inc. (CDMO): A Bull Case Theory

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

Reuters

a month ago

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

Zacks

a month ago

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

Argus Research

a month ago

CTLT: Raising target price to $62.00

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Zacks

a month ago

Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up

Argus Research

a month ago

CTLT: Lowering target price to $61.00

Morningstar Research

a month ago

Analyst Report: Catalent, Inc.

MT Newswires

a month ago

Catalent Fiscal Q1 Net Loss Flat, Revenue Gains

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings

Reuters

a month ago

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings

Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates

Zacks

a month ago

Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates

Associated Press Finance

a month ago

Catalent: Fiscal Q1 Earnings Snapshot

Investing.com

a month ago

Catalent reports Q1 loss, misses market expectations

Catalent, Inc. Reports First Quarter Fiscal 2025 Results

Business Wire

a month ago

Catalent, Inc. Reports First Quarter Fiscal 2025 Results

MT Newswires

a month ago

Market Chatter: Novo Holdings to Receive European Decision on Catalent Acquisition by Dec. 6

EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6

Reuters

a month ago

EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6

Catalent to sell New Jersey drug facility to Ardena

Manufacturing Dive

2 months ago

Catalent to sell New Jersey drug facility to Ardena

Backlash builds against Novo’s Catalent takeover

Pharma Voice

2 months ago

Backlash builds against Novo’s Catalent takeover

CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases

Zacks

2 months ago

CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Benzinga

2 months ago

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

MT Newswires

2 months ago

Update: Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO

MT Newswires

2 months ago

Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO

Merck acquires cancer drug startup; Elevidys ex-US sales rise

BioPharma Dive

2 months ago

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Roche comes out against allowing takeover of drug manufacturer Catalent

Reuters

2 months ago

Roche comes out against allowing takeover of drug manufacturer Catalent

Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year?

Zacks

2 months ago

Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year?

MT Newswires

2 months ago

Catalent to Continue Operating as CDMO After Novo Holdings Buyout, CEO Says

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout

Reuters

2 months ago

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout

Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings

Business Wire

2 months ago

Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings

MT Newswires

2 months ago

European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock

MT Newswires

2 months ago

Novo Nordisk-Catalent Deal Faces Opposition From Consumer Groups Over Competition Concerns

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Reuters

2 months ago

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Catalent Stock Flat Following the Sell Agreement With Ardena

Zacks

2 months ago

Catalent Stock Flat Following the Sell Agreement With Ardena

MT Newswires

2 months ago

Catalent to Sell Oral Solids Facility in New Jersey to Ardena

Catalent to sell New Jersey facility

Reuters

2 months ago

Catalent to sell New Jersey facility

Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility

Business Wire

2 months ago

Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility

MT Newswires

2 months ago

Update: Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent

MT Newswires

2 months ago

Update: Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent

MT Newswires

2 months ago

Senator Warren Asks US Antitrust Regulator to 'Carefully Scrutinize' Novo Nordisk's Bid for Catalent

US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal

Reuters

2 months ago

US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal

Argus Research

2 months ago

CTLT: Raising target price to $64.00

The Zacks Analyst Blog Highlights AppLovin, Duolingo, Paramount, Twilio and Catalent

Zacks

2 months ago

The Zacks Analyst Blog Highlights AppLovin, Duolingo, Paramount, Twilio and Catalent

More Interest Rate Cuts Ahead: 5 Growth Stocks to Benefit

Zacks

3 months ago

More Interest Rate Cuts Ahead: 5 Growth Stocks to Benefit

TAK or CTLT: Which Is the Better Value Stock Right Now?

Zacks

3 months ago

TAK or CTLT: Which Is the Better Value Stock Right Now?

MT Newswires

3 months ago

Baird Downgrades Catalent to Neutral From Outperform, Price Target is $63.50

Do Options Traders Know Something About Catalent (CTLT) Stock We Don't?

Zacks

3 months ago

Do Options Traders Know Something About Catalent (CTLT) Stock We Don't?

Catalent (CTLT) Upgraded to Strong Buy: Here's What You Should Know

Zacks

3 months ago

Catalent (CTLT) Upgraded to Strong Buy: Here's What You Should Know

Decoding Catalent Inc (CTLT): A Strategic SWOT Insight

GuruFocus.com

3 months ago

Decoding Catalent Inc (CTLT): A Strategic SWOT Insight

Morningstar Research

3 months ago

Analyst Report: Catalent, Inc.

Catalent delays filing of annual report

Reuters

4 months ago

Catalent delays filing of annual report

Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up

Zacks

4 months ago

Catalent's Stock Gains on Q4 Earnings Beat, Gross Margin Up

MT Newswires

4 months ago

Sector Update: Health Care Stocks Advance Premarket Thursday

Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates

Zacks

4 months ago

Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates

MT Newswires

4 months ago

Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb

Catalent beats revenue estimates ahead of deal close with Novo Holdings

Reuters

4 months ago

Catalent beats revenue estimates ahead of deal close with Novo Holdings

Associated Press Finance

4 months ago

Catalent: Fiscal Q4 Earnings Snapshot

Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results

Business Wire

4 months ago

Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results

Argus Research

4 months ago

CTLT: What does Argus have to say about CTLT?

Argus Research

4 months ago

CTLT: What does Argus have to say about CTLT?

Should You Invest In Catalent, Inc. (CTLT) Right Now?

Insider Monkey

4 months ago

Should You Invest In Catalent, Inc. (CTLT) Right Now?

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

Zacks

4 months ago

JAZZ or CTLT: Which Is the Better Value Stock Right Now?

MT Newswires

5 months ago

Catalent Insider Sold Shares Worth $534,011, According to a Recent SEC Filing

Argus Research

5 months ago

CTLT: What does Argus have to say about CTLT?

Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?

Simply Wall St.

5 months ago

Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?

UTHR vs. CTLT: Which Stock Is the Better Value Option?

Zacks

5 months ago

UTHR vs. CTLT: Which Stock Is the Better Value Option?

Argus Research

5 months ago

CTLT: Raising target price to $61.00

Catalent (CTLT) Expands Its Facility Capabilities in Germany

Zacks

5 months ago

Catalent (CTLT) Expands Its Facility Capabilities in Germany

UTHR vs. CTLT: Which Stock Should Value Investors Buy Now?

Zacks

5 months ago

UTHR vs. CTLT: Which Stock Should Value Investors Buy Now?

MT Newswires

5 months ago

Catalent Completes $25 Million Expansion of Schorndorf Site

Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany

Business Wire

5 months ago

Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany

UTHR or CTLT: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

UTHR or CTLT: Which Is the Better Value Stock Right Now?

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 07/11/2024

Share on Social Networks: